Related Experiment Video

Updated: Mar 29, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.4K

[New Pathogenetic Concepts and Pharmacological Studies on Adjuvant Therapy in Severe Pneumonia]

J Lienau1, H Müller-Redetzky1, N Suttorp1

  • 1Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie.

Pneumologie (Stuttgart, Germany)
|December 5, 2015
PubMed

Insights

Effective treatments for pneumonia-induced acute lung injury are limited. This review explores novel adjuvant therapies targeting inflammation and lung barrier function to prevent respiratory failure.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Critical Care

Background:

  • Pneumonia can lead to acute lung injury (ALI) due to immune system dysregulation.
  • Hyperinflammation and compromised alveolar-capillary barriers characterize ALI in pneumonia.
  • Current treatments for ALI in pneumonia, beyond antibiotics, are insufficient.

Purpose of the Study:

  • To review adjuvant therapeutic strategies for ALI secondary to pneumonia.
  • To highlight approaches for modulating inflammation and stabilizing lung barrier function.

Main Methods:

  • Literature review of preclinical studies on ALI in pneumonia.
  • Analysis of novel therapeutic targets and strategies.
  • Focus on immune modulation and barrier repair.

Main Results:

  • Preclinical research has identified promising therapeutic targets for ALI.
  • Novel strategies show potential in protecting against pneumonia-induced lung failure.
  • Adjuvant therapies can modulate inflammation and enhance lung barrier integrity.

Conclusions:

  • Adjuvant therapies offer a promising avenue for managing ALI in pneumonia.
  • Targeting inflammation and barrier function may prevent pneumonia-related respiratory complications.
  • Further research into these strategies is warranted for clinical translation.

More Related Videos

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

9.7K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.3K

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K